Skip to main content

Advertisement

SpringerLink
Log in

Lysosomal storage disorders: emerging therapeutic options require early diagnosis

  • Article
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Lysosomal storage disorders have been recognised as one of the major groups of genetic disorders affecting children and adults. With over 40 different disorders and a combined prevalence of up to 1:5000 births, this group of disorders is a major public health problem and places an enormous burden on the individuals and families affected. Since the introduction of enzyme replacement therapy for Gaucher disease over 10 years ago there has been considerable progress in the development of enzyme based therapies for other disorders, in addition to alternate therapies including substrate deprivation and gene based therapies. Early diagnosis of these disorders before the onset of irreversible pathologies will lead to better outcomes for current and proposed therapies.

In this review we describe the strategies and technology being used for the development of newborn screening for lysosomal storage disorders and discuss the future requirements for the early diagnosis and effective therapy of this group of disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

LAMP :

lysosomal associated membrane protein

LSD :

lysosomal storage disorder

MPS :

mucopolysaccharidosis

NCL :

neuronal ceroid lipofuscinosis

REFERENCES

  1. Beutler E, Grabowski GA (1995) Gaucher disease. In: Scriver CR, Beaudet AC, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease vol II, 7th edn. McGraw-Hill, New York, pp 2641–2670

  2. Bunge S, Clements PR, Byers S, Kleijer WJ, Brooks DA, Hopwood JJ (1998) Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies. Biochim Biophys Acta 1407: 249–256

    Article  CAS  PubMed  Google Scholar 

  3. Chang MHY, Bindloss CA, Grabowski GA, Qi X, Winchester B, Hopwood JJ, Meikle PJ (2000) Evaluation of saposins as potential diagnostic markers for lysosomal storage disorders. Clin Chem 46: 167–174

    CAS  PubMed  Google Scholar 

  4. Crawley AC, Brooks DA, Muller VJ, Petersen BA, Isaac EL, Bielicki J, King BM, Boulter CD, Moore AJ, Fazzalari NL, Anson DS, Byers S, Hopwood JJ (1996) Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome. J Clin Invest 97: 1864–1873

    CAS  Google Scholar 

  5. Ferrara ML, Taylor RM, Stewart GJ (1992) Age at marrow transplantation is critical for successful treatment of canine fucosidosis. Transplant Proc 24: 2282–2283

    CAS  Google Scholar 

  6. Gahl WA, Reed GF, Thoene JG et al (1987) Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med 316: 971–977

    CAS  PubMed  Google Scholar 

  7. Gelb BD, Shi GP, Chapman HA, Desnick RJ (1996) Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273: 1236–1238

    CAS  PubMed  Google Scholar 

  8. Hoogerbrugge PM, Valerio D (1998) Bone marrow transplantation and gene therapy for lysosomal storage diseases. Bone Marrow Transplant 21[Suppl 2]: S34–S36

    Google Scholar 

  9. Hoogerbrugge PM, Brouwer OF, Bordigoni P, Ringden O, Kapaun P, Ortega JJ, O’Meara A, Cornu G, Souillet G, Frappaz D (1995) Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation (see comments). Lancet 345: 1398–1402

    Article  CAS  PubMed  Google Scholar 

  10. Hopwood JJ, Brooks DA (1997) An introduction to the basic science and biology of the lysosome and storage diseases. In: Applegarth DA, Dimmick JE, Hall JG (eds) Organelle diseases. Chapman and Hall Medical, London, pp 7–36

  11. Hopwood JJ, Vellodi A, Scott HS, Morris CP, Litjens T, Clements PR, Brooks DA, Cooper A, Wraith JE (1993) Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype. J Inherit Metab Dis 16: 1024–1033

    CAS  PubMed  Google Scholar 

  12. Hua CT, Hopwood JJ, Carlsson SR, Harris RJ, Meikle PJ (1998) Evaluation of the lysosome-associated membrane protein lamp-2 as a marker for lysosomal storage disorders. Clin Chem 44: 2094–2102

    CAS  PubMed  Google Scholar 

  13. Krivit W, Aubourg P, Shapiro E, Peters C (1999) Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. Curr Opin Hematol 6: 377–382

    Article  CAS  PubMed  Google Scholar 

  14. Meikle PJ, Brooks DA, Ravenscroft EM, Yan M, Williams RE, Jaunzems AE, Chataway TK, Karageorgos LE, Davey R C, Boulter CD, Carlsson SR, Hopwood JJ (1997) Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker. Clin Chem 43: 1325–1335

    CAS  PubMed  Google Scholar 

  15. Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281: 249–254

    CAS  PubMed  Google Scholar 

  16. Petersen GM, Rotter JI, Cantor RM, Field LL, Greenwald S, Lim JS, Roy C, Schoenfeld V, Lowden JA, Kaback MM (1983) The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin. Am J Hum Genet 35: 1258–1269

    CAS  PubMed  Google Scholar 

  17. Rider JA, Rider DL (1988) Batten disease: past, present, and future. Am J Med Genet Suppl 5: 21–26

    CAS  PubMed  Google Scholar 

  18. Rozaklis T, Ramsay SL, Whitfield PD, Ranieri E, Hopwood JJ, Meikle PJ (2001) Determination of oligosaccharides in Pompe disease by electrospray ionisation tandem mass spectrometry. Clin Chem 48: 131–139

    Google Scholar 

  19. Sleat DE, Donnelly RJ, Lackland H, Liu CG, Sohar I, Pullarkat RK, Lobel P (1997) Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 277: 1802–1805

    Article  CAS  PubMed  Google Scholar 

  20. Vesa J, Hellsten E, Verkruyse LA, Camp LA, Rapola J, Santavuori P, Hofmann SL, Peltonen L (1995) Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376: 584–587

    CAS  PubMed  Google Scholar 

  21. Whitfield PD, Nelson P, Sharp PC, Bindloss CA, Dean C, Ravenscroft EM, Fong BA, Fietz MJ, Hopwood JJ, Meikle PJ (2001) Correlation between genotype, phenotype and biochemical markers in Gaucher disease: implications for the prediction of disease severity. Mol Gen Metab 75: 46–55

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lysosomal Diseases Research Unit, Department of Genetic Medicine, Women’s and Children’s Hospital, 72 King William Road, Adelaide SA, Australia

    Peter J. Meikle & John J. Hopwood

Authors
  1. Peter J. Meikle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John J. Hopwood
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meikle, P.J., Hopwood, J.J. Lysosomal storage disorders: emerging therapeutic options require early diagnosis. Eur J Pediatr 162 (Suppl 1), S34–S37 (2003). https://doi.org/10.1007/s00431-003-1348-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-003-1348-y

Keywords

Search

Navigation